Literature DB >> 2921453

Drug-induced illness as a cause for admission to a community hospital.

H G Colt1, A P Shapiro.   

Abstract

To assess the rate of occurrence of drug-induced illness as a cause for admission to the general medicine service of a community hospital, charts were reviewed retrospectively of all patients admitted to the service over two randomly selected one-month periods. Statistical analysis was performed on patients over and under the age of 65, and on iatrogenic and noniatrogenic admissions. Twenty-three of 244 patients (9.4%) were admitted with drug-induced illness. Patients with drug-induced illness had 5.7 medications as compared to 3.2 medications per patient admitted for other reasons (P less than .05). A single drug was responsible for 61% of all drug-induced illness admissions. Aspirin and other nonsteroidal anti-inflammatory agents were most often implicated. Eighteen of 155 elderly patients (11.7%) were admitted with drug-induced illness. These patients were on an average of 6.3 medications as compared with 3.8 medications per elderly patient admitted for other causes (P less than .005). Polypharmacy and a preponderantly elderly population may explain the substantial number of admissions caused by adverse drug reactions. Further research to assess the role of patient age and the number and type of medications involved in the event of drug-induced illness requires standardization of definition and diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921453     DOI: 10.1111/j.1532-5415.1989.tb05498.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  31 in total

Review 1.  Adverse reactions as a cause of hospital admission in the aged.

Authors:  K Beard
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

2.  Assessing the usability of a telemedicine-based Medication Delivery Unit for older adults through inspection methods.

Authors:  Frank M Ligons; Katrina M Romagnoli; Suzanne Browell; Harry S Hochheiser; Steven M Handler
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

3.  Emergency care and the patient in the long-term care facility.

Authors:  M Gordon; K C Klapecki; D B Wilson
Journal:  CMAJ       Date:  1991-07-01       Impact factor: 8.262

4.  The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.

Authors:  Robyn Tamblyn; Allen Huang; Robert Perreault; André Jacques; Denis Roy; James Hanley; Peter McLeod; Réjean Laprise
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

Review 5.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

6.  Innovative collaborative practice to optimize pharmacotherapy for frail older patients.

Authors:  Shanna Trenaman; Susan K Bowles; Laurie Mallery; Katalin Koller; Melissa Andrew
Journal:  Can J Hosp Pharm       Date:  2014-09

7.  Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs.

Authors:  L Gallelli; M Colosimo; D Pirritano; M Ferraro; S De Fazio; N M Marigliano; G De Sarro
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

8.  Questionable prescribing for elderly patients in Quebec.

Authors:  R M Tamblyn; P J McLeod; M Abrahamowicz; J Monette; D C Gayton; L Berkson; W D Dauphinee; R M Grad; A R Huang; L M Isaac
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

9.  The geriatric medication algorithm: a pilot study.

Authors:  P F Newton; W Levinson; D Maslen
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

10.  Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older.

Authors:  W Kruse; J Rampmaier; C Frauenrath-Volkers; D Volkert; I Wankmüller; W Micol; P Oster; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.